Qube Research & Technologies (QRT)
IMVT icon

Qube Research & Technologies (QRT)’s Immunovant IMVT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-220,346
Closed -$7.12M – 4251
2024
Q1 		$7.12M Buy
220,346
+188,689
+596% +$6.88M 0.01% 1027
2023
Q4 		$1.33M Buy
+31,657
New +$1.16M ﹤0.01% 1756
2022
Q2 		– Sell
-35,382
Closed -$195K – 2803
2022
Q1 		$195K Buy
+35,382
New +$220K ﹤0.01% 1950
2021
Q3 		– Sell
-37,453
Closed -$396K – 2472
2021
Q2 		$396K Buy
+37,453
New +$523K ﹤0.01% 1403

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMVT Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Immunovant (IMVT) in Q2 2024, closing a stake of 220,346 shares — an estimated $7.12M sold.

Qube Research & Technologies (QRT) first reported a position in IMVT in Q2 2021 and held it in 4 quarters. The position peaked at $7.12M in Q1 2024. 197 funds tracked by Wall St. Rank hold IMVT as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Immunovant position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 220,346 Immunovant shares in Q2 2024, an estimated $7.12M.
  • Qube Research & Technologies (QRT) first reported a position in Immunovant in Q2 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Immunovant position peaked at $7.12M in Q1 2024.
  • 197 funds tracked by Wall St. Rank held Immunovant as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.